{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:33:56Z","timestamp":1791516836779,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,5,28]],"date-time":"2015-05-28T00:00:00Z","timestamp":1432771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s10456-015-9469-2","type":"journal-article","created":{"date-parts":[[2015,5,27]],"date-time":"2015-05-27T01:56:07Z","timestamp":1432691767000},"page":"313-326","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study"],"prefix":"10.1007","volume":"18","author":[{"given":"Mikko T.","family":"Visuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista M.","family":"Honkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauliina","family":"Hartiala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomi V.","family":"Tervala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paavo J.","family":"Halonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Junkkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Knuutinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seppo","family":"Yl\u00e4-Herttuala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari K.","family":"Alitalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Saarikko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,28]]},"reference":[{"key":"9469_CR1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/jemt.1163","volume":"55","author":"MH Witte","year":"2001","unstructured":"Witte MH, Bernas MJ, Martin CP, Witte CL (2001) Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology. Microsc Res Tech 55:122\u2013145. doi: 10.1002\/jemt.1163","journal-title":"Microsc Res Tech"},{"key":"9469_CR2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04480","volume":"438","author":"K Alitalo","year":"2005","unstructured":"Alitalo K, Tammela T, Petrova TV (2005) Lymphangiogenesis in development and human disease. Nature 438:946\u2013953. doi: 10.1038\/nature04480","journal-title":"Nature"},{"key":"9469_CR3","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/CIRCULATIONAHA.107.704098","volume":"123","author":"C Norrm\u00e9n","year":"2011","unstructured":"Norrm\u00e9n C, Tammela T, Petrova TV, Alitalo K (2011) Biological basis of therapeutic lymphangiogenesis. Circulation 123:1335\u20131351. doi: 10.1161\/CIRCULATIONAHA.107.704098","journal-title":"Circulation"},{"key":"9469_CR4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0002-9343(00)00727-0","volume":"110","author":"SG Rockson","year":"2001","unstructured":"Rockson SG (2001) Lymphedema. Am J Med 110:288\u2013295","journal-title":"Am J Med"},{"key":"9469_CR5","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1097\/PRS.0b013e3181f44658","volume":"126","author":"H Suami","year":"2010","unstructured":"Suami H, Chang DW (2010) Overview of surgical treatments for breast cancer-related lymphedema. Plast Reconstr Surg 126:1853\u20131863. doi: 10.1097\/PRS.0b013e3181f44658","journal-title":"Plast Reconstr Surg"},{"key":"9469_CR6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/bjs.6658","volume":"96","author":"RJ Damstra","year":"2009","unstructured":"Damstra RJ, Voesten HGJM, Klinkert P, Brorson H (2009) Circumferential suction-assisted lipectomy for lymphoedema after surgery for breast cancer. Br J Surg 96:859\u2013864. doi: 10.1002\/bjs.6658","journal-title":"Br J Surg"},{"key":"9469_CR7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(81)90723-6","volume":"1","author":"RG Baumeister","year":"1981","unstructured":"Baumeister RG, Seifert J, Hahn D (1981) Autotransplantation of lymphatic vessels. Lancet 1:147","journal-title":"Lancet"},{"key":"9469_CR8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s10147-005-0518-5","volume":"10","author":"T Nagase","year":"2005","unstructured":"Nagase T, Gonda K, Inoue K, Higashino T, Fukuda N, Gorai K, Mihara M, Nakanishi M, Koshima I (2005) Treatment of lymphedema with lymphaticovenular anastomoses. Int J Clin Oncol 10:304\u2013310","journal-title":"Int J Clin Oncol"},{"key":"9469_CR9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/micr.20968","volume":"32","author":"G Felmerer","year":"2012","unstructured":"Felmerer G, Sattler T, Lohrmann C, Tobbia D (2012) Treatment of various secondary lymphedemas by microsurgical lymph vessel transplantation. Microsurgery 32:171\u2013177. doi: 10.1002\/micr.20968","journal-title":"Microsurgery"},{"key":"9469_CR10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.sla.0000201258.10304.16","volume":"243","author":"C Becker","year":"2006","unstructured":"Becker C, Assouad J, Riquet M, Hidden G (2006) Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation. Ann Surg 243:313\u2013315. doi: 10.1097\/01.sla.0000201258.10304.16","journal-title":"Ann Surg"},{"key":"9469_CR11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/SLA.0b013e3182426757","volume":"255","author":"AM Saaristo","year":"2012","unstructured":"Saaristo AM, Niemi TS, Viitanen TP, Tervala TV, Hartiala P, Suominen EA (2012) Microvascular breast reconstruction and lymph node transfer for postmastectomy lymphedema patients. Ann Surg 255:468\u2013473. doi: 10.1097\/SLA.0b013e3182426757","journal-title":"Ann Surg"},{"key":"9469_CR12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1083\/jcb.115.1.85","volume":"115","author":"RE Mebius","year":"1991","unstructured":"Mebius RE, Streeter PR, Brev\u00e9 J, Duijvestijn AM, Kraal G (1991) The influence of afferent lymphatic vessel interruption on vascular addressin expression. J Cell Biol 115:85\u201395","journal-title":"J Cell Biol"},{"key":"9469_CR13","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/CIRCULATIONAHA.110.965384","volume":"123","author":"M L\u00e4hteenvuo","year":"2011","unstructured":"L\u00e4hteenvuo M, Honkonen K, Tervala T, Tammela T, Suominen E, L\u00e4hteenvuo J, Kholov\u00e1 I, Alitalo K, Yl\u00e4-Herttuala S, Saaristo A (2011) Growth factor therapy and autologous lymph node transfer in lymphedema. Circulation 123:613\u2013620. doi: 10.1161\/CIRCULATIONAHA.110.965384","journal-title":"Circulation"},{"key":"9469_CR14","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/SLA.0b013e31826ed043","volume":"257","author":"KM Honkonen","year":"2013","unstructured":"Honkonen KM, Visuri MT, Tervala TV, Halonen PJ, Koivisto M, L\u00e4hteenvuo MT, Alitalo KK, Yl\u00e4-Herttuala S, Saaristo AM (2013) Lymph node transfer and perinodal lymphatic growth factor treatment for lymphedema. Ann Surg 257:961\u2013967. doi: 10.1097\/SLA.0b013e31826ed043","journal-title":"Ann Surg"},{"key":"9469_CR15","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1084\/jem.20020587","volume":"196","author":"A Saaristo","year":"2002","unstructured":"Saaristo A, Veikkola T, Tammela T, Enholm B, Karkkainen MJ, Pajusola K, Bueler H, Yl\u00e4-Herttuala S, Alitalo K (2002) Lymphangiogenic gene therapy with minimal blood vascular side effects. J Exp Med 196:719\u2013730","journal-title":"J Exp Med"},{"key":"9469_CR16","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1096\/fj.02-0401fje","volume":"16","author":"A Szuba","year":"2002","unstructured":"Szuba A, Skobe M, Karkkainen MJ, Shin WS, Beynet DP, Rockson NB, Dakhil N, Spilman S, Goris ML, Strauss HW, Quertermous T, Alitalo K, Rockson SG (2002) Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J 16:1985\u20131987. doi: 10.1096\/fj.02-0401fje","journal-title":"FASEB J"},{"key":"9469_CR17","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/nm1689","volume":"13","author":"T Tammela","year":"2007","unstructured":"Tammela T, Saaristo A, Holopainen T, Lyytikk\u00e4 J, Kotronen A, Pitkonen M, Abo-Ramadan U, Yl\u00e4-Herttuala S, Petrova TV, Alitalo K (2007) Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation. Nat Med 13:1458\u20131466. doi: 10.1038\/nm1689","journal-title":"Nat Med"},{"key":"9469_CR18","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/bcr2638","volume":"12","author":"A Baker","year":"2010","unstructured":"Baker A, Kim H, Semple JL, Dumont D, Shoichet M, Tobbia D, Johnston M (2010) Experimental assessment of pro-lymphangiogenic growth factors in the treatment of post-surgical lymphedema following lymphadenectomy. Breast Cancer Res 12:R70\u2013R70. doi: 10.1186\/bcr2638","journal-title":"Breast Cancer Res"},{"key":"9469_CR19","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1093\/emboj\/16.13.3898","volume":"16","author":"V Joukov","year":"1997","unstructured":"Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, Saksela O, Kalkkinen N, Alitalo K (1997) Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 16:3898\u20133911. doi: 10.1093\/emboj\/16.13.3898","journal-title":"EMBO J"},{"key":"9469_CR20","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1073\/pnas.95.2.548","volume":"95","author":"MG Achen","year":"1998","unstructured":"Achen MG, Jeltsch M, Kukk E, M\u00e4kinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95:548\u2013553","journal-title":"Proc Natl Acad Sci USA"},{"key":"9469_CR21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ceb.2008.12.012","volume":"21","author":"M Lohela","year":"2009","unstructured":"Lohela M, Bry M, Tammela T, Alitalo K (2009) VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21:154\u2013165. doi: 10.1016\/j.ceb.2008.12.012","journal-title":"Curr Opin Cell Biol"},{"key":"9469_CR22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","volume":"473","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298\u2013307. doi: 10.1038\/nature10144","journal-title":"Nature"},{"key":"9469_CR23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/j.1460-2075.1996.tb00359.x","volume":"15","author":"V Joukov","year":"1996","unstructured":"Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290\u2013298","journal-title":"EMBO J"},{"key":"9469_CR24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/75997","volume":"25","author":"MJ Karkkainen","year":"2000","unstructured":"Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, Alitalo K, Finegold DN (2000) Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 25:153\u2013159. doi: 10.1038\/75997","journal-title":"Nat Genet"},{"key":"9469_CR25","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/emboj\/20.6.1223","volume":"20","author":"T Veikkola","year":"2001","unstructured":"Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, Petrova TV, Kubo H, Thurston G, McDonald DM, Achen MG, Stacker SA, Alitalo K (2001) Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 20:1223\u20131231. doi: 10.1093\/emboj\/20.6.1223","journal-title":"EMBO J"},{"key":"9469_CR26","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.pathmechdis.3.121806.151515","volume":"3","author":"T Karpanen","year":"2008","unstructured":"Karpanen T, Alitalo K (2008) Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol Mech Dis 3:367\u2013397. doi: 10.1146\/annurev.pathmechdis.3.121806.151515","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"9469_CR27","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1096\/fj.01-1042com","volume":"16","author":"A Saaristo","year":"2002","unstructured":"Saaristo A, Veikkola T, Enholm B, Hyt\u00f6nen M, Arola J, Pajusola K, Turunen P, Jeltsch M, Karkkainen MJ, Kerjaschki D, Bueler H, Yl\u00e4-Herttuala S, Alitalo K (2002) Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J 16:1041\u20131049. doi: 10.1096\/fj.01-1042com","journal-title":"FASEB J"},{"key":"9469_CR28","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/01.RES.0000073584.46059.E3","volume":"92","author":"TT Rissanen","year":"2003","unstructured":"Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen MI, Kholov\u00e1 I, Kauppinen RA, Achen MG, Stacker SA, Alitalo K, Yl\u00e4-Herttuala S (2003) VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res 92:1098\u20131106. doi: 10.1161\/01.RES.0000073584.46059.E3","journal-title":"Circ Res"},{"key":"9469_CR29","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1161\/01.CIR.0000115519.03688.A2","volume":"109","author":"J Rutanen","year":"2004","unstructured":"Rutanen J, Rissanen TT, Markkanen JE, Gruchala M, Silvennoinen P, Kivel\u00e4 A, Hedman A, Hedman M, Heikura T, Ord\u00e9n M, Stacker SA, Achen MG, Hartikainen J, Yl\u00e4-Herttuala S (2004) Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation 109:1029\u20131035. doi: 10.1161\/01.CIR.0000115519.03688.A2","journal-title":"Circulation"},{"key":"9469_CR30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/hum.2006.100","volume":"18","author":"I Kholov\u00e1","year":"2007","unstructured":"Kholov\u00e1 I, Koota S, Kaskenp\u00e4\u00e4 N, Lepp\u00e4nen P, N\u00e4rv\u00e4inen J, Kavec M, Rissanen TT, Hazes T, Korpisalo P, Gr\u00f6hn O, Yl\u00e4-Herttuala S (2007) Adenovirus-mediated gene transfer of human vascular endothelial growth factor-D induces transient angiogenic effects in mouse hind limb muscle. Hum Gene Ther 18:232\u2013244. doi: 10.1089\/hum.2006.100","journal-title":"Hum Gene Ther"},{"key":"9469_CR31","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.1074\/jbc.273.12.6599","volume":"273","author":"V Joukov","year":"1998","unstructured":"Joukov V, Kumar V, Sorsa T, Arighi E, Weich H, Saksela O, Alitalo K (1998) A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J Biol Chem 273:6599\u20136602","journal-title":"J Biol Chem"},{"key":"9469_CR32","first-page":"1599","volume":"58","author":"L Jussila","year":"1998","unstructured":"Jussila L, Valtola R, Partanen TA, Salven P, Heikkil\u00e4 P, Matikainen M, Renkonen R, Kaipainen A, Detmar M, Tschachler E, Alitalo R, Alitalo K (1998) Lymphatic endothelium and Kaposi\u2019s sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res 58:1599\u20131604","journal-title":"Cancer Res"},{"key":"9469_CR33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1369\/jhc.4A6514.2005","volume":"54","author":"MP Pusztaszeri","year":"2006","unstructured":"Pusztaszeri MP, Seelentag W, Bosman FT (2006) Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues. J Histochem Cytochem 54:385\u2013395. doi: 10.1369\/jhc.4A6514.2005","journal-title":"J Histochem Cytochem"},{"key":"9469_CR34","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14:500\u2013515. doi: 10.1016\/S1470-2045(13)70076-7","journal-title":"Lancet Oncol"},{"key":"9469_CR35","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(93)90573-9","volume":"72","author":"B Millauer","year":"1993","unstructured":"Millauer B, Wizigmann-Voos S, Schn\u00fcrch H, Martinez R, M\u00f8ller NPH, Risau W, Ullrich A (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835\u2013846","journal-title":"Cell"},{"key":"9469_CR36","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1084\/jem.20062642","volume":"204","author":"M Wirzenius","year":"2007","unstructured":"Wirzenius M, Tammela T, Uutela M, He Y, Odorisio T, Zambruno G, Nagy JA, Dvorak HF, Yl\u00e4-Herttuala S, Shibuya M, Alitalo K (2007) Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting. J Exp Med 204:1431\u20131440. doi: 10.1084\/jem.20062642","journal-title":"J Exp Med"},{"key":"9469_CR37","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1073\/pnas.92.8.3566","volume":"92","author":"A Kaipainen","year":"1995","unstructured":"Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh Victor W M, Fang G, Dumont D, Breitman M, Alitalo K (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A 92:3566\u20133570","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9469_CR38","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1096\/fj.06-6656com","volume":"21","author":"J Goldman","year":"2007","unstructured":"Goldman J, Rutkowski JM, Shields JD, Pasquier MC, Cui Y, Schm\u00f6kel HG, Willey S, Hicklin DJ, Pytowski B, Swartz MA (2007) Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis. FASEB J 21:1003\u20131012. doi: 10.1096\/fj.06-6656com","journal-title":"FASEB J"},{"key":"9469_CR39","doi-asserted-by":"crossref","first-page":"40973","DOI":"10.1074\/jbc.M304499200","volume":"278","author":"J Dixelius","year":"2003","unstructured":"Dixelius J, M\u00e4kinen T, Wirzenius M, Karkkainen MJ, Wernstedt C, Alitalo K, Claesson-Welsh L (2003) Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites. J Biol Chem 278:40973\u201340979. doi: 10.1074\/jbc.M304499200","journal-title":"J Biol Chem"},{"key":"9469_CR40","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/emboj.2010.30","volume":"29","author":"I Nilsson","year":"2010","unstructured":"Nilsson I, Bahram F, Li X, Gualandi L, Koch S, Jarvius M, S\u00f6derberg O, Anisimov A, Kholov\u00e1 I, Pytowski B, Baldwin M, Yl\u00e4 Herttuala S, Alitalo K, Kreuger J, Claesson-Welsh L (2010) VEGF receptor 2\/-3 heterodimers detected in situ by proximity ligation on angiogenic sprouts. EMBO J 29:1377\u20131388. doi: 10.1038\/emboj.2010.30","journal-title":"EMBO J"},{"key":"9469_CR41","doi-asserted-by":"crossref","first-page":"8176","DOI":"10.1074\/jbc.M112.439299","volume":"288","author":"NC Harris","year":"2013","unstructured":"Harris NC, Davydova N, Roufail S, Paquet-Fifield S, Paavonen K, Karnezis T, Zhang Y, Sato T, Rothacker J, Nice EC, Stacker SA, Achen MG (2013) The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology. J Biol Chem 288:8176\u20138186. doi: 10.1074\/jbc.M112.439299","journal-title":"J Biol Chem"},{"key":"9469_CR42","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/blood-2010-02-267427","volume":"117","author":"S Nakao","year":"2011","unstructured":"Nakao S, Zandi S, Hata Y, Kawahara S, Arita R, Schering A, Sun D, Melhorn MI, Ito Y, Lara-Castillo N, Ishibashi T, Hafezi-Moghadam A (2011) Blood vessel endothelial VEGFR-2 delays lymphangiogenesis: an endogenous trapping mechanism links lymph- and angiogenesis. Blood 117:1081\u20131090. doi: 10.1182\/blood-2010-02-267427","journal-title":"Blood"},{"key":"9469_CR43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tcm.2011.11.008","volume":"20","author":"P Hartiala","year":"2010","unstructured":"Hartiala P, Saaristo AM (2010) Growth factor therapy and autologous lymph node transfer in lymphedema. Trends Cardiovasc Med 20:249\u2013253. doi: 10.1016\/j.tcm.2011.11.008","journal-title":"Trends Cardiovasc Med"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-015-9469-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10456-015-9469-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-015-9469-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T12:29:47Z","timestamp":1566736187000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10456-015-9469-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,28]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["9469"],"URL":"https:\/\/doi.org\/10.1007\/s10456-015-9469-2","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,28]]}}}